Good morning Chairwoman, Eshoo, Ranking Member Burgess and distinguished Members of the Subcommittee. Thank you for inviting me to testify today. (Editor's Note: House Energy and Commerce)

I am Dr. Rick Bright, a career public servant and a scientist who has spent 25 years of my career focused on addressing pandemic outbreaks. I received my bachelor’s degree with honors in both biology and physical sciences from Auburn University at Montgomery in Alabama. I earned my PhD in Immunology and Molecular Pathogenesis from Emory University in Georgia.  My dissertation was focused on pandemic avian influenza. I have spent my entire career leading teams of scientists in drugs, diagnostics and vaccine development — in the government with CDC and BARDA, for a global non-profit organization and also in the biotechnology industry. Regardless of my position, my job and my entire professional focus has been on saving lives. My professional background has prepared me for a moment like this – to confront and defeat a deadly virus like COVID-19 that threatens Americans and people around the globe.

I joined the Biomedical Advanced Research and Development Authority (BARDA) in 2010 and from November of 2016 until April 21 of this year, I had the privilege of serving our country as its Director. During the time I was Director of BARDA we successfully partnered with private industry to achieve an unprecedented number of FDA approvals for medical countermeasures against a wide variety of national health security threats. This was a major and unprecedented accomplishment and one that I and the conscientious employees of BARDA take great pride in.

As I reflect on the past few months of this outbreak, it is painfully clear that we were not as prepared as we should have been. We missed early warning signals and we forgot important pages from our pandemic playbook. There will be plenty of time to identify gaps for improvement. For now, we need to focus on getting things right going forward. We need to ensure that we have a plan to recovery and that everyone knows the plan and everyone participates in the plan. Congress has taken important steps to support the response; and we have more to do. We need your help to get us through the crisis.

We Americans, working cooperatively with our global friends, can and will succeed in finding a cure for COVID19, but that success depends on what we do today. We must unite and use all available tools and measures we have to stem the damage this virus has wrought.

We will either be remembered for what we did or for what we failed to do to address this crisis. I call on all of us to act — to ensure the health, safety, and prosperity of all Americans. You can count on me to continue to do my part.

Pages: 1 · 2 · 3

More Articles

• FactCheck.org: Q&A on Trump’s COVID-19 Diagnosis
• Covid 19 Hearing Sept 16th: CDC Director Dr. Redfield Testified on the Latest Coronavirus Response Efforts
• Clinical Trials of Monoclonal Antibodies to Prevent COVID-19 Now Enrolling Healthy Adults Who Are At Risk of Infection Due to Close Contact at Work or Home to Persons with SARS-CoV-2 Infection
• Remarks by President Obama on Research for Potential Ebola Vaccine, December 02, 2014
• US Department of Justice, Combatting CoronaVirus Fraud: Phishing Emails Posing as the World Health Organization or the Centers for Disease Control and Prevention
• Travelers from Countries with Widespread Sustained Transmission of COVID-19 Arriving in the US; CDC is Working to Implement After-travel Health Precautions and EPA Disinfectants for Use Against SARS-CoV-2
• Weekly National Summary of Week 50: Outpatient Illness Surveillance, Geographic Spread, Mortality Surveillance
• From the CDC (Centers for Disease Control and Prevention) For the Public: What You Need to Know About Vaping
• STIs Are Contributing to the Public Health Crisis as Cases of Gonorrhea, Syphilis and Chlamydia Are All On the Rise
• GAO** Reports: Electronic Cigarettes - US Imports and the Value of US E-cigarette Imports was $2.4 billion; CDC and FDA Campaigns